Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual GIP/GLP-1 Receptor Agonist in Women With Obesity for Frozen Embryo Transfer
NCT07811895Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Randomised, open-label trial of tirzepatide in obesity (2 arms), sponsored by Renji Hospital. Primary endpoint: Good birth outcome rate. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07811895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07811895.